Ignite Creation Date:
2025-12-24 @ 12:07 PM
Ignite Modification Date:
2025-12-31 @ 4:43 PM
Study NCT ID:
NCT05144061
Status:
COMPLETED
Last Update Posted:
2024-12-18
First Post:
2021-10-12
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A First-in-human Study of HRS2398 Tablets in Subjects With Advanced Malignant Tumors
Sponsor:
Shanghai Hengrui Pharmaceutical Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-12-20
Start Date Type:
ACTUAL
Primary Completion Date:
2024-02-21
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-02-21
Completion Date Type:
ACTUAL
First Submit Date:
2021-10-12
First Submit QC Date:
None
Study First Post Date:
2021-12-03
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-12-17
Last Update Post Date:
2024-12-18
Last Update Post Date Type:
ACTUAL